title: Tumor necrosis factor-associated palmoplantar pustular psoriasis treated with interleukin 6 blocker.
authors.forename: Said
authors.initials: S
authors.lastname: Younis
authors.forename: Doron
authors.initials: D
authors.lastname: Rimar
authors.forename: Gleb
authors.initials: G
authors.lastname: Slobodin
authors.forename: Itzhak
authors.initials: I
authors.lastname: Rosner
mesh_terms: D000068879:Adalimumab; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects* / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008875:Middle Aged; D011565:Psoriasis / Q000139:chemically induced* / Q000188:drug therapy*; D019947:Receptors, Interleukin-6 / Q000037:antagonists & inhibitors; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D019947:Receptors, Interleukin-6; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab; C502936:tocilizumab